|
|
Office Locations:
|
2788 San Tomas Expressway
Santa Clara, CA 95051
| | |
|
|
|
Electronics & Advanced Materials
Information Technology
Semiconductor
Software & Internet
|
|
|
NVentures is NVIDIA's venture capital arm. The firm invests in technology visionaries solving complex problems to reshape our world. Through a unique mix of expertise and resources, NVentures build long-term partnerships with bold teams to accelerate their journeys.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
COMPANY STAGE | REVENUE |
Venture Capital | |
Seed Stage (includes "pre-seed," or concept stage) | No Revenue |
Early Stage | Minimal Revenue |
Growth Stage (also called Mid-stage) | $2M-$7M |
Expansion Stage (also called Late-stage) | $7M and greater |
Private Equity | |
Lower Middle Market | $10M-$249M |
Middle Market | $250M-$499M |
Upper Middle Market | $500M-$1B |
Large Cap | >$1B |
|
|
|
|
|
Name | |
| |
Title | |
|
Artem Barsukov | |
| |
Investment Director | |
Mohamed (Sid) Siddeek | |
| |
Head of NVentures | |
|
|
|
Date
|
Name
|
State
|
Amount
|
Stage
|
01/11/2024
|
Neocis
|
FL
|
$20,000,000
|
|
10/30/2023
|
Seurat Technologies
|
MA
|
$99,000,000
|
Series C
|
10/05/2023
|
Machina Labs
|
CA
|
$32,000,000
|
Series B
|
09/29/2023
|
Evozyne
|
IL
|
$81,000,000
|
Series B
|
09/14/2023
|
Generate:Biomedicines
|
MA
|
$273,000,000
|
Series C
|
08/21/2023
|
Genesis Therapeutics
|
CA
|
$200,000,000
|
Series B
|
|
|
|
|
|